![](https://investorshub.advfn.com/uicon/75.png?cb=1513767336)
Thursday, May 10, 2018 11:50:57 AM
The two new consultants are:
Dr. Linda Klumpers has joined our drug development team as a consultant. Dr. Klumpers has a Ph.D. in Clinical Pharmacology from the Leiden University Medical Center in the Netherlands and Professor Schoser of the Frederich-Baur Institut at the University of Munich has also joined our drug development team as a consultant. Dr. Schoser is a Myotonic Dystrophy specialist, which is one of the medical conditions for which we are developing a cannabinoid-based pharmaceutical.
Intiva goes on to explain:
Our innovative research and development strategy, consisting of bringing together an endo-cannabinoid scientist, Dr. Klumpers, with an indication specialist such as Professor Schoser, we believe will prove to be very beneficial. These seasoned and leading specialists are sharing their very specific and in-depth knowledge to benefit Intiva by potentially developing new ways of treating medical disorders with cannabinoid-based medications.
With the recent news regarding Syria using nerve agents against its own population, the use of nerve agents, including sarin gas, is once-again a front-page story. Intiva has licensed intellectual property regarding the use of cannabinoid-based drugs for alleviating some of the symptoms resulting from the exposure to organophosphates, including insecticides and nerve agents. Intiva intends to proceed in the development of cannabinoid and terpene-based formulations, with the objective of filing one or more New Drug Applications (NDAs) with the FDA, probably under special "animal only" protocols for national defense and first responders, since nerve agents cannot be tested on humans. Our pre-clinical drug development activities for the nerve agent product are proceeding. Our formulation lab is currently developing test batches, consisting of synthetic THC and other cannabinoids, so that pre-clinical work can be initiated.
Intiva also gives information regarding XactDose:
Intiva has also licensed a patent and intellectual property for the exact dosing of pill-based cannabinoid medicine. We have branded this product as XactDose. Our business plan for XactDose is to license the technology to the medical cannabis industry globally.
Alain Bankier ends the Intiva letter by acknowledging us, their loyal investors in Intiva:
On behalf of your management team and directors, we thank you for your trust and support. We will keep you apprised as Intiva BioPharma proceeds in implementing its business plans.
I, for one, look forward to new information as it becomes available. Thanks Intiva Management Team.
Recent NXEN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 03:58:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 03:57:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 10:19:44 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 11:19:50 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 11:04:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:02:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:02:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 10:06:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2023 09:41:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2023 07:35:14 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM